two
genet
highli
similar
biotyp
coronavirus
describ
cat
felin
infecti
periton
viru
fipv
felin
enter
coronaviru
fecv
coronavirus
infect
cat
member
felida
famili
infect
fecv
usual
subclin
except
young
kitten
may
caus
mild
sever
diarrhoea
contrast
fipv
infect
caus
chronic
often
fatal
pleuritisperiton
fact
import
caus
death
infecti
origin
cat
cat
clinic
fip
often
high
titer
fipvspecif
antibodi
yet
antibodi
abl
block
infect
suggest
antibodi
antibodydriven
immun
effector
abl
effici
clear
bodi
viru
andor
virusinfect
cell
previou
work
present
immun
evas
strategi
use
fipv
could
clarifi
antibodi
seem
unabl
identifi
infect
cell
andor
mark
antibodydepend
cell
lysi
found
half
infect
monocyt
express
viral
protein
surfac
cell
express
viral
protein
protein
internalis
upon
antibodi
addit
highli
effici
fast
process
result
fipvinfect
cell
without
visual
detect
viral
protein
plasma
membran
fact
viral
antigen
found
fipv
infect
monocyt
isol
natur
infect
fip
cat
express
return
vitro
cultiv
strong
indic
immun
evas
strategi
occur
vivo
went
elucid
internalis
pathway
antigenantibodi
complex
internalis
ligand
internalis
cell
via
sever
pathway
classic
pathway
phagocytosi
macropinocytosi
clathrinmedi
internalis
caveolaemedi
internalis
extens
review
reader
refer
less
well
defin
nonclass
pathway
latter
pathway
distinguish
one
anoth
depend
raft
dynamin
rhogtpas
two
pathway
depend
dynamin
first
pathway
use
interleukin
receptor
uptak
leukocyt
depend
raft
unidentifi
rhogtpas
pathway
might
also
use
cellular
prion
protein
second
dynamindepend
nonclass
pathway
actin
rhokinas
depend
independ
raft
use
intracellular
adhes
plateletendotheli
cell
adhes
dynaminindepend
pathway
depend
raft
rhogtpas
utilis
gpianchor
protein
like
folat
receptor
anoth
dynaminindepend
pathway
use
menk
diseas
atpas
defect
copper
transport
atpas
also
independ
raft
regul
rhogtpas
third
dynaminindepend
internalis
pathway
present
previou
work
pathway
viral
surfac
express
protein
fipv
infect
monocyt
internalis
pathway
fifth
nonclass
pathway
occur
independ
raft
dynamin
rhogtpas
sure
pathway
await
discoveri
internalis
vesicl
need
activ
transport
get
dens
protein
rich
cytosol
around
cytoskeleton
compon
toward
final
destin
longrang
transport
get
cell
peripheri
cell
centr
run
microtubul
mediat
motor
protein
dynein
kinesin
transport
cell
peripheri
shortrang
transport
insid
cell
mediat
actin
associ
motor
protein
myosin
endosom
push
forward
polymeris
actin
filament
form
actin
tail
transport
myosin
actin
filament
format
actin
tail
describ
varieti
internalis
pathway
phagocytosi
movement
phagosom
mediat
actin
tail
macrophag
dictyostelium
also
macropinosom
propel
actin
tail
toward
cell
centr
clathrinmedi
internalis
actin
implic
sever
step
internalis
process
mammalian
yeast
cell
howev
actin
requir
seem
depend
cell
type
experiment
condit
format
actin
tail
seen
clathrinco
pit
internalis
event
initi
movement
small
actin
tail
polymeris
caveola
shortli
internalis
induc
simian
viru
actin
comet
tail
also
report
endosom
lysosom
hela
cell
cultur
mast
cell
nih
cell
bud
yeast
xenopu
egg
movement
mediat
actin
tail
defin
direct
run
actin
track
contrast
transport
mediat
myosin
motor
run
actin
filament
direct
dictat
myosin
myosin
class
ii
v
vi
vii
xi
x
known
play
role
one
internalis
pathway
howev
myosin
mainli
associ
first
step
internalis
membran
remodel
pinch
vesicl
far
report
role
myosin
traffick
endosom
mous
hepatoma
cell
myosin
analogu
human
myosin
contribut
traffick
lysosom
along
microtubul
myosin
transport
recent
uncoat
vesicl
cortic
actin
barrier
clathrinmedi
internalis
nonpolaris
epitheli
cell
myosin
play
role
outbound
traffick
secretori
vesicl
aim
studi
clarifi
recent
characteris
pathway
use
surfac
express
antigen
fipv
infect
monocyt
regul
role
play
microtubul
actin
myosin
internalis
experi
show
myosin
light
chain
kinas
mlck
myosin
myosin
microtubl
actin
involv
antibodyinduc
internalis
fipv
infect
monocyt
third
passag
fipv
strain
american
type
cultur
collect
atcc
crfk
cell
use
fipv
strain
type
strain
studi
extens
even
though
type
strain
predomin
field
type
coronavirus
easili
propag
vitro
polyclon
antifcov
antibodi
kindli
provid
p
rottier
utrecht
univers
netherland
antibodi
purifi
biotinyl
accord
manufactur
instruct
amersham
bioscienc
buckinghamshir
uk
fitclabel
polyclon
antifipv
antibodi
purchas
veterinari
medic
research
develop
vmrd
pullman
washington
usa
monoclon
antibodi
recognis
n
protein
kindli
provid
hohdatsu
kitasato
univers
japan
monocyt
marker
recognis
purchas
vmrd
rabbit
antitubulin
polyclon
antibodi
monoclon
antibodi
nonmuscl
myosin
purchas
abcam
cambridg
uk
rabbit
polyclon
antibodi
nonmuscl
myosin
sigmaaldrich
steinheim
germani
goat
polyclon
mlck
rabbit
polyclon
antibodi
myosin
santa
cruz
biotechnolog
santa
cruz
california
usa
secondari
antibodi
reagent
goat
antimous
texa
red
goat
antimous
alexa
fluor
streptavidin
texa
red
streptavidin
fitc
streptavidin
alexa
fluor
antirabbit
alexa
fluor
zenon
reagent
purchas
molecular
probe
molecular
probesinvitrogen
eugen
oregon
usa
felin
monocyt
isol
describ
previous
cell
seed
glass
coverslip
insert
dish
nunc
roskild
denmark
medium
contain
fetal
bovin
serum
fb
mgml
glutamin
uml
penicillin
mgml
streptomycin
mgml
kanamycin
uml
heparin
mm
sodium
pyruv
nonessenti
aminoacid
gibcoinvitrogen
merelbek
belgium
nonadher
cell
remov
wash
dish
two
time
h
seed
adher
cell
consist
monocyt
assess
fluoresc
stain
monocyt
marker
h
post
seed
monocyt
inocul
fipv
multipl
infect
cell
analys
per
assay
twelv
hour
inocul
monocyt
seed
glass
coverslip
preincub
min
presenc
one
follow
agent
dissolv
rpmi
latrunculin
b
icn
biochem
inc
ohio
usa
cytochalasin
sigmaaldrich
gmbh
steinheim
germani
nm
jasplakinolid
molecular
probe
colchicin
sigmaaldrich
gmbh
nocodazol
sigmaaldrich
gmbh
paclitaxel
calbiochem
san
diego
california
usa
nm
bisindolylmaleimid
calbiochem
calbiochem
nm
calbiochem
calbiochem
pkg
inhibitor
calbiochem
nm
calbiochem
blebbistatin
sigmaaldrich
gmbh
work
concentr
reagent
base
literatur
valu
optimis
qualit
internalis
assay
control
ligand
data
shown
viabil
cell
inhibit
assay
test
inhibitor
use
ethidium
bromid
monoazid
molecular
probesinvitrogen
alway
pretreat
cell
incub
polyclon
biotinyl
antifipv
antibodi
presenc
one
given
inhibitor
min
cell
fix
formaldehyd
permeabil
triton
sigmaaldrich
gmbh
incub
streptavidintexa
red
h
next
infect
cell
visualis
polyclon
antifipvfitc
glass
coverslip
mount
microscop
slide
use
glycerinepb
solut
volvol
octan
dabco
janssen
chimica
beers
belgium
analys
confoc
microscopi
percentag
cell
fulli
internalis
complex
calcul
rel
total
amount
monocyt
show
antibodi
bind
thu
membran
express
antibodi
ad
monocyt
constitut
total
amount
infect
cell
variabl
amount
cell
membran
express
visualis
complex
remain
plasma
membran
need
therefor
acid
wash
step
remov
extracellular
antibodi
perform
test
effect
reagent
suitabl
control
use
experi
monocyt
seed
glass
coverslip
preincub
min
presenc
one
inhibitor
treatment
cell
incub
biotinyl
transferrin
sigmaaldrich
gmbh
fluoresc
polystyren
microspher
fluospher
molecular
probesinvitrogen
presenc
inhibitor
cell
fix
formaldehyd
permeabil
triton
biotinyl
transferrin
visualis
incub
cell
streptavidinfitc
h
cell
incub
fluoresc
bead
incub
phalloidintexa
red
molecular
probesinvitrogen
h
visualis
lamellipodia
glass
coverslip
mount
microscop
slide
use
glycerinedabco
analys
confoc
microscopi
control
monocyt
score
analog
fipvinfect
cell
ligand
consid
fulli
internalis
observ
insid
cell
fluoresc
bead
consid
internalis
found
insid
cortic
actin
label
twelv
hour
inocul
monocyt
incub
biotinyl
antifipv
polyclon
antibodi
differ
time
post
antibodi
addit
cell
fix
formaldehyd
permeabil
triton
antigenantibodi
complex
visualis
streptavidinfitc
follow
block
step
neg
goat
serum
next
actin
filament
microtubul
mlck
myosin
stain
cell
incub
phalloidintexa
red
visualis
actin
filament
stain
microtubul
polyclon
rabbit
antitubulin
antibodi
tag
antirabbit
alexa
fluor
zenon
reagent
visualis
mlck
goat
polyclon
use
follow
rabbit
antigoat
alexa
fluor
visualis
myosin
monoclon
antimyosin
use
follow
goat
antimous
texa
red
visualis
myosin
rabbit
antimyosin
tag
antirabbit
alexa
fluor
zenon
reagent
min
incub
cell
fix
stabilis
zenon
reagent
final
infect
cell
visualis
monoclon
antin
goat
antimous
alexa
fluor
shown
imag
colocalis
myosin
mlck
internalis
process
infect
monocyt
incub
antifipv
polyclon
antibodi
differ
time
post
antibodi
addit
cell
fix
formaldehyd
permeabil
triton
mlck
visualis
goat
antimlck
biotinyl
donkey
antigoat
streptavidin
alexa
fluor
neg
goat
serum
block
myosin
visualis
mous
antimyosin
goat
antimous
texa
red
internalis
antigenantibodi
complex
visualis
goat
anticat
fitc
sampl
stain
describ
examin
leica
tc
spe
laser
scan
spectral
confoc
system
leica
microsystem
gmbh
wetzlar
germani
link
dm
irb
invert
microscop
leica
microsystem
argon
heliumneon
laser
light
use
excit
fitc
nm
line
texa
red
nm
line
fluorochrom
violet
diod
laser
use
excit
alexa
fluor
nm
line
imag
obtain
leica
confoc
softwar
process
gimp
triplic
assay
compar
use
mannwithney
u
test
spss
spss
inc
chicago
wa
p
valu
consid
significantli
differ
serinethreonin
kinas
biggest
group
kinas
consist
differ
class
among
protein
kinas
c
pkc
protein
kinas
pka
cyclic
ampdepend
protein
kinas
protein
kinas
g
pkg
cyclic
gmpdepend
protein
kinas
famili
calciumcalmodulindepend
protein
kinas
camk
myosin
light
chain
kinas
mlck
import
class
test
perform
internalis
assay
presenc
pharmacolog
inhibitor
pkc
known
regul
fc
receptor
complement
receptor
mannos
receptormedi
phagocytosi
pka
mlck
shown
mediat
phagocytosi
neutrophil
inhibit
target
fluoresc
bead
chosen
control
ligand
pkc
known
regul
fc
receptor
complement
receptor
mannos
receptormedi
phagocytosi
pka
mlck
shown
mediat
phagocytosi
neutrophil
internalis
viral
antigen
remain
unaffect
presenc
bisindolylmaleimid
pkcinhibitor
pkainhibitor
pkginhibitor
camk
iiinhibitor
internalis
control
ligand
reduc
respect
repres
imag
result
given
figur
addit
confirm
infect
presenc
antibodi
induc
internalis
affect
activ
inhibitor
direct
major
internalis
pathway
data
shown
contrast
specif
mlck
inhibitor
could
inhibit
internalis
viral
antigen
untreat
control
uptak
bead
control
ligand
equival
reduc
figur
import
mlck
reinforc
anoth
mlck
inhibitor
also
inhibit
internalis
viral
antigen
control
ligand
bead
similar
level
figur
b
describ
literatur
mlck
regul
myosin
phosphoryl
regulatori
light
chain
bind
thu
addit
internalis
inhibit
assay
perform
blebbistatin
myosin
inhibitor
investig
involv
myosin
test
indic
internalis
antigenantibodi
complex
could
block
blebbistatin
uptak
bead
could
figur
b
indic
myosin
involv
internalis
process
investig
colocalis
stain
antigenantibodi
complex
myosin
mlck
figur
show
indic
role
myosin
found
mlck
clearli
coloc
alreadi
addit
antibodi
see
figur
mlck
remain
associ
viral
antigenantibodi
complex
least
min
antibodi
addit
min
associ
lost
sinc
experi
suggest
myosin
involv
internalis
process
investig
myosin
involv
myosin
select
base
role
sever
internalis
process
internalis
experi
colocalis
found
myosin
viral
antigen
time
point
data
shown
contrast
viral
antigen
colocalis
myosin
similar
mlck
previou
experi
myosin
highli
enrich
plasma
membran
right
underneath
viral
protein
see
panel
azoom
figur
alreadi
antibodi
ad
shortli
addit
antibodi
myosin
reloc
internalis
complex
plasma
membran
see
panel
bzoom
figur
antigenantibodi
complex
move
cell
maintain
associ
myosin
min
antibodi
addit
loss
interact
first
observ
eg
centr
cell
depict
panel
e
figur
dissoci
myosin
internalis
complex
occur
time
pass
vesicl
reach
centr
cell
colocalis
myosin
also
observ
quickli
addit
antibodi
antigenantibodi
complex
right
plasma
membran
see
panel
figur
associ
lost
soon
viral
antigenantibodi
complex
move
insid
cell
illustr
panel
figur
imag
panel
actual
differ
section
cell
clearli
illustr
shortliv
myosin
associ
internalis
complex
later
time
point
cell
colocalis
still
found
never
actin
cortex
eg
panel
jzoom
figur
suggest
colocalis
repres
antigenantibodi
complex
start
internalis
moment
fixat
test
whether
mlck
could
involv
regul
myosin
assess
myosin
would
associ
antigenantibodi
complex
presenc
mlck
inhibitor
imag
figur
show
cell
treat
associ
antigenantibodi
complex
myosin
strongli
affect
occur
small
fraction
complex
min
post
antibodi
addit
small
fraction
remain
associ
myosin
howev
complex
internalis
myosin
stain
cell
pretreat
associ
could
seen
antibodi
addit
similar
untreat
cell
min
post
antibodi
addit
substanti
amount
associ
seen
call
myosin
seem
intact
sinc
effect
inhibit
internalis
mere
associ
myosin
andor
enough
function
sinc
pattern
myosin
associ
internalis
antigenantibodi
complex
resembl
mlck
pattern
previou
experi
indic
recruit
myosin
affect
inhibit
mlck
colocalis
stain
antigenantibodi
complex
myosin
mlck
done
figur
confirm
internalis
complex
myosin
mlck
fulli
coloc
initi
step
internalis
process
min
post
antibodi
addit
vesicl
appear
still
carri
myosin
mlck
associ
lost
probabl
shortli
associ
myosin
also
lost
seen
figur
result
confirm
mlck
might
regul
myosin
myosin
involv
intern
process
track
motor
protein
actin
filament
may
also
involv
investig
role
actin
internalis
pathway
internalis
assay
perform
presenc
inhibitor
cytochalasin
inhibit
format
new
filament
latrunculin
b
disrupt
actin
filament
jasplakinolid
stabilis
exist
filament
induc
polymeris
new
filament
figur
show
repres
confoc
imag
monocyt
min
addit
antibodi
presenc
one
inhibitor
cell
treat
cytochalasin
latrunculin
b
show
internalis
viral
antigenantibodi
complex
pattern
similar
untreat
control
cell
monocyt
treat
jasplakinolid
also
internalis
viral
antigenantibodi
complex
howev
typic
pattern
randomli
distribut
internalis
complex
observ
fewer
internalis
vesicl
seem
travel
far
cell
untreat
monocyt
monocyt
treat
cytochalasin
latrunculin
b
monocyt
treat
jasplakinolid
one
expect
cortic
actin
network
might
even
extens
untreat
cell
polymeris
induc
capac
drug
nevertheless
almost
filament
actin
seen
imag
monocyt
tri
internalis
fluoresc
bead
figur
reason
appar
discrep
jasplakinolid
imped
phalloidintexa
red
bind
actin
filament
result
vagu
red
cell
even
though
cortic
actin
network
present
quantif
internalis
presenc
inhibitor
confirm
cytochalasin
latrunculin
b
signific
effect
internalis
process
inhibitor
strongli
reduc
phagocytosi
fluoresc
bead
respect
untreat
control
figur
result
suggest
actin
filament
requir
internalis
process
treatment
monocyt
jasplakinolid
gave
small
signific
reduct
internalis
untreat
control
suggest
stabilis
cortic
actin
network
might
hamper
slow
internalis
antigenantibodi
complex
sinc
internalis
process
could
block
disrupt
actin
filament
internalis
stop
stabilis
filament
conclud
actin
play
activ
role
internalis
process
elucid
role
actin
internalis
process
actin
filament
visualis
phalloidintexa
red
differ
time
initi
internalis
confoc
imag
figur
show
min
addit
antibodi
antigenantibodi
complex
move
cell
internalis
site
local
absenc
cortic
actin
could
observ
could
actin
filament
move
broken
order
make
way
internalis
complex
provid
explan
jasplakinolid
reduc
slow
internalis
anoth
noteworthi
observ
made
later
stage
internalis
process
figur
show
vesicl
pass
cortic
actin
network
still
associ
actin
way
resembl
actin
tail
associ
internalis
vesicl
actin
still
observ
min
initi
internalis
lost
min
treat
cell
combin
latrunculin
b
investig
lift
actin
barrier
would
enough
enabl
internalis
mlck
thu
myosin
also
requir
initi
internalis
process
found
internalis
presenc
inhibitor
reduc
significantli
differ
inhibit
assay
alon
indic
activ
mlck
requir
initi
internalis
process
see
figur
cell
treat
latrunculin
b
min
post
antibodi
addit
take
result
togeth
mlck
play
role
initi
internalis
process
contrast
actin
might
requir
internalis
indic
inhibit
assay
cytochalasin
latrunculin
b
actin
stain
result
actin
stabilis
drug
jasplakinolid
indic
cortic
actin
network
form
barrier
slow
internalis
must
overcom
move
disintegr
actin
filament
addit
actin
mlck
may
play
activ
role
transport
cell
sinc
fulli
internalis
complex
associ
actin
tail
mlck
primari
rout
vesicl
move
plasma
membran
toward
cell
centr
run
microtubul
internalis
studi
fast
effici
process
internalis
antigenantibodi
complex
found
centr
cell
soon
min
addit
antibodi
section
verifi
internalis
vesicl
transport
microtubul
reach
cell
centr
first
internalis
assay
perform
presenc
one
follow
inhibitor
colchicin
nocodazol
disrupt
microtubul
paclitaxel
promot
assembl
inhibit
disassembl
microtubul
imag
figur
show
internalis
could
still
occur
presenc
either
inhibitor
sinc
antigenantibodi
complex
observ
insid
monocyt
howev
internalis
vesicl
remain
close
plasma
membran
indic
transport
centr
cell
inhibit
quantif
reveal
decreas
internalis
monocyt
treat
colchicin
nocodazol
untreat
control
respect
figur
thu
transport
inhibit
internalis
well
treatment
paclitaxel
also
led
decreas
internalis
albeit
less
pronounc
inhibitor
untreat
control
sinc
paclitaxel
drug
stabilis
microtubul
find
indic
microtubul
must
intact
must
also
remain
dynam
although
decreas
significantli
differ
minor
compar
strong
reduct
internalis
control
ligand
transferrin
untreat
control
indic
requir
dynam
microtubul
stringent
internalis
pathway
studi
clathrinmedi
internalis
transferrin
confirm
role
microtubul
transport
internalis
vesicl
microtubul
visualis
internalis
process
confoc
imag
figur
show
internalis
vesicl
associ
microtubul
soon
min
initi
internalis
thu
microtubul
base
transport
start
like
right
passag
cortic
actin
network
min
first
vesicl
alreadi
reach
microtubul
organis
centr
mtoc
associ
internalis
vesicl
microtubul
maintain
test
time
point
taken
togeth
find
indic
antigenantibodi
complex
transport
microtubul
toward
cell
centr
accumul
mtoc
primari
felin
monocyt
infect
fipv
vitro
fraction
express
spike
protein
membran
protein
found
plasma
membran
half
infect
cell
contrast
viral
antigen
detect
plasma
membran
monocyt
isol
form
natur
infect
cat
mimick
vivo
situat
ad
antibodi
vitro
cultur
fipvinfect
monocyt
found
protein
quickli
effici
internalis
heterocomplex
leav
plasma
membran
clear
visual
detect
viral
antigen
internalis
antigenantibodi
complex
occur
via
new
clathrin
caveolaeindepend
pathway
requir
dynamin
raft
rhogtpas
sinc
antigenantibodi
complex
internalis
transport
toward
cell
centr
rapidli
want
investig
internalis
process
initi
intracellular
transport
organis
import
myosin
motor
internalis
best
studi
phagocytosi
myosin
cooper
start
complet
process
role
myosin
internalis
process
less
well
establish
myosin
associ
macropinocytosi
clathrinmedi
internalis
myosin
clathrinmedi
internalis
colocalis
stain
myosin
internalis
process
studi
suggest
myosin
might
drive
forc
behind
membran
invagin
describ
myosin
formerli
known
might
inde
coupl
polymer
actin
membran
thu
mediat
forc
product
endocytosi
constrain
possibl
orient
actin
assembl
sever
studi
mention
myosin
involv
format
internalis
vesicl
found
patch
myosin
could
observ
viral
protein
resid
plasma
membran
could
bind
antibodi
viral
protein
induc
conform
chang
expos
signal
sequenc
cytoplasmat
tail
protein
lead
activ
internalis
machineri
colocalis
stain
also
indic
role
myosin
first
step
internalis
process
nonpolaris
epitheli
cell
short
isoform
myosin
transport
recent
uncoat
vesicl
actin
barrier
myosin
motor
coupl
dimer
mediat
direct
movement
filament
actin
network
cortic
actin
studi
present
use
primari
monocyt
nonpolaris
cell
contain
cortic
actin
network
highli
probabl
myosin
perform
task
name
transport
internalis
antigenantibodi
complex
cortic
actin
result
show
mlck
requir
internalis
process
myosin
myosin
literatur
state
mlck
substrat
specif
restrict
regulatori
light
chain
myosin
howev
research
done
muscl
cell
mlck
shown
function
differ
nonmuscl
cell
possibl
member
mlck
famili
restrict
myosin
research
blue
colleagu
inde
shown
kda
nonmuscl
mlck
isoform
colocalis
myosin
colocalis
actin
filament
result
hint
toward
exist
mlck
isoform
regul
myosin
suggest
colocalis
kinet
myosin
colocalis
visualis
mlck
isoform
internalis
process
find
recruit
myosin
antigenantibodi
complex
hamper
treatment
inhibitor
block
catalyt
activ
mlck
prevent
phosphoryl
substrat
myosin
find
myosin
mlck
alreadi
associ
viral
antigen
addit
antibodi
thu
internalis
indic
mere
bind
mlck
enough
kinas
activ
import
role
actin
investig
found
internalis
pathway
studi
dynam
actin
prerequisit
hypothesi
corrobor
colocalis
stain
clearli
show
cortic
actin
network
form
barrier
must
move
asid
local
degrad
allow
internalis
vesicl
pass
similar
observ
made
clathrinor
caveolaemedi
internalis
internalis
process
studi
myosin
andor
could
play
role
move
cortic
actin
role
least
myosin
sinc
take
away
cortic
actin
treat
thu
mlck
inact
cell
enabl
internalis
combin
find
myosin
alreadi
associ
antigen
antibodi
bind
strongli
suggest
myosin
requir
initi
step
internalis
process
eg
membran
remodel
pass
internalis
vesicl
transport
microtubul
track
switch
actin
microtubul
might
mediat
myosin
soon
vesicl
move
microtubul
associ
myosin
lost
associ
myosin
maintain
could
myosin
actin
filament
cooper
microtubul
intracellular
traffick
similar
observ
made
mous
hepatoma
cell
myosin
analogu
human
myosin
contribut
traffick
lysosom
along
microtubul
control
direction
longrang
movement
evid
accumul
exist
motor
complex
combin
actin
microtubulebas
transport
although
effort
focus
myosin
outbound
traffick
studi
also
indic
myosin
control
constrain
actin
polymeris
rather
promot
nucleat
experi
inde
show
intracellular
transport
requir
dynam
polymeris
actin
possibl
actin
tail
internalis
vesicl
requir
propel
vesicl
mere
help
orient
traffick
toward
cell
centr
control
myosin
constrain
actin
polymeris
hypothet
model
combin
result
internalis
process
indic
endosom
marker
found
previou
work
given
figur
research
interest
target
new
therapi
fipv
aris
mlck
inhibit
mlck
internalis
process
could
effici
block
enabl
immun
system
host
recognis
elimin
infect
cell
antiimmun
evas
therapi
whole
new
approach
treat
chronic
infecti
diseas
import
advantag
classic
antivir
therapi
cellular
target
use
henc
problem
drug
resist
treatment
might
useabl
immuneevad
virus
might
lead
elimin
viru
sinc
viru
pool
target
conclus
clathrin
caveolaeindepend
internalis
pathway
surfac
express
viral
protein
internalis
antibodi
bind
fipvinfect
monocyt
initi
driven
myosin
mlck
requir
actin
experi
indic
myosin
might
drive
forc
internalis
process
activ
phosphoryl
mlck
passag
cortic
actin
network
myosin
associ
antigenantibodi
complex
well
pass
cortic
actin
microtubulebas
transport
start
associ
myosin
lost
transport
microtubul
vesicl
associ
small
actin
tail
mlck
myosin
indic
actin
microtubul
cooper
intracellular
traffick
probabl
mediat
myosin
min
internalis
vesicl
reach
microtubul
organis
centr
accumul
actin
tail
mlck
myosin
associ
lost
min
hld
hjn
current
appli
patent
mlck
therapeut
target
hld
hjn
conceiv
studi
hld
design
perform
experi
analys
data
wrote
manuscript
yn
lmd
perform
experi
inhibitor
author
read
approv
final
manuscript
